ROSA DUNN: Open Payments
NPI 1508607029 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 40 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 6 | $280 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $251 |
| Collegium Pharmaceutical, Inc. | 14 | $250 |
| PROTEGA PHARMACEUTIALS INC | 3 | $50 |
| ABBVIE INC. | 2 | $41 |
| IBSA Pharma Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: PROLATE, RELISTOR, XTAMPZA, Nucynta, ROXYBOND, Belbuca, UBRELVY, Tirosint.
Industry payments across NV — which companies pay providers there.
